The growing problem of co-treatment with opioids and benzodiazepines
BMJ
.
2017 Mar 14:356:j1224.
doi: 10.1136/bmj.j1224.
Authors
Pinar Karaca-Mandic
1
,
Ellen Meara
2
,
Nancy E Morden
2
Affiliations
1
Division of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN 55455-0381, USA.
2
Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Hanover, NH 03755-1404, USA.
PMID:
28292825
PMCID:
PMC6283389
DOI:
10.1136/bmj.j1224
Abstract
A powerful example of potentially dangerous low value care
Publication types
Editorial
Comment
MeSH terms
Analgesics, Opioid*
Benzodiazepines*
Humans
Opioid-Related Disorders
Substances
Analgesics, Opioid
Benzodiazepines
Grants and funding
P01 AG019783/AG/NIA NIH HHS/United States